Joining Novo Holdings
A career with Asia Investments
Advancing life sciences investment across Asia's thriving markets
Novo Holdings Asia was established in 2020 with the aim of harnessing a growing and attractive life sciences market in Asia. With offices in Singapore and Shanghai, our team supports healthcare companies across the continent, with a tailored approach to accommodate regional nuances.
As an investor, we have full flexibility to participate across company life cycles and modalities including public equities, minority investments, co-investments, and buyouts. Our investments cover a range of healthcare subsectors, including MedTech, life sciences tools and diagnostics, pharma services, healthcare IT, patient services, and planetary health.
Our current geographical focus includes India, China, and Southeast Asia, with a strategy of selecting and managing high-quality assets featuring reputable management teams and innovative science or business models
Shape innovation with us in Asia's life sciences and healthcare
As of year-end 2024, the Asia team comprises 15 employees with diverse backgrounds and complementary skill sets. We draw on our collective experience to identify, invest in, and manage a portfolio of innovative life science and healthcare companies. The team is attuned to the region’s diverse markets and regulatory environments, balancing local insights with global perspectives. Strategic partnerships and relationship-building are highly valued, reflecting the importance of trust and long-term connections in the region.
“My experience with the Novo Holdings Asia team has been characterised by a steep learning curve. I am impressed and motivated by the strong sense of ownership that permeates the organisation, encompassing both the deal and business support teams. The flat structure of the organisation ensures excellent exposure and learning opportunities. Our “One Asia” culture fosters seamless collaboration across offices, and the highly supportive environment makes the work experience enriching. Additionally, we have fun bonding together through various activities such as team building events and community service.”
Paloma Pan
Vice President, Asia Investments
Our investment mandate and assets
By the end of 2024, Asia Investments was managing a portfolio of 12 companies, of which five were based in India, four in China, and three in Southeast Asia, with a total portfolio value of approximately USD 512 million.
“Working at Novo Holdings Asia has been both an enriching and fulfilling experience. It is an immensely satisfying experience to see our healthcare investments creating a deep and positive impact on millions of people across Asia. Trust, respect, and performance are the pillars that define the culture of Novo Holdings. The collaborative spirit and innovative mindset create an environment where everyone feels valued and empowered to contribute. The company’s commitment to continuous learning is evident through various workshops and training sessions. The culture within the Asia team is one of mutual respect and inclusivity. While we hail from different countries, there is a genuine sense of camaraderie and a shared drive to achieve our goals while celebrating each other’s successes.”
Navjeewan Khosla
Asia Investments